Dentsply Sirona Inc (XRAY)

Dentsply Sirona Inc. (NASDAQ: XRAY) is a Healthcare company in the Healthcare Equipment & Supplies industry. Its listed security is common stock, and it should be understood in that common equity security context. The company is associated with dental and oral healthcare equipment, as well as related consumable products and clinical tools used by healthcare professionals. It also has exposure to broader medical device categories connected to patient care. As a NASDAQ-listed share, XRAY represents an ownership interest in the company rather than a separate fund, debt instrument, or special security. This overview reflects the security classification and broad business profile.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-XRAY
$14.28
51.4% Upside
Bargain
$12.53
32.9% Upside
Undervalued
Good
6.8%
November 5, 2026
1.4x
0.5x
1.88 B
3.968 B
55.3%
94.2%
1.2
-17.6%
-26.2%
Valuation • Fair Value

Dentsply Sirona Inc (NASDAQ-XRAY) Fair Value by Valuation Model

Review the available estimates for Dentsply Sirona Inc (NASDAQ-XRAY), including DCF Fair Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$14.28

Estimated upside of 51.4% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$16.73

Discounted cash flow valuation reference.

EPV Fair Value

$8.76

Earnings power value estimate.

Comps Fair Value

$12.74

Comparable-company valuation reference.

Analyst Price Target

$12.53

Analysts imply upside of 32.9%.

How to read these valuation models

Use the 6 available valuation references for Dentsply Sirona Inc (NASDAQ-XRAY) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Dentsply Sirona Inc (NASDAQ-XRAY)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

3.643 B

Current operating scale indicator.

Revenue Forecast

3.576 B

Forward revenue estimate.

EBITDA

526 M

Current operating profitability reference.

EBITDA Forecast

625.4 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Dentsply Sirona Inc (NASDAQ-XRAY) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Dentsply Sirona Inc (NASDAQ-XRAY)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-3.37

No elevated caution signal from this screen.

Altman Z-Score

1.2

Lower score that deserves closer risk review.

FCF / Net Income

-26.2%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Dentsply Sirona Inc (NASDAQ-XRAY). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Dentsply Sirona Inc (NASDAQ-XRAY)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 5, 2026

Days to Earnings

12

Dividend Yield

6.8%

Current income yield reference.

Payout Ratio

-17.6%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Dentsply Sirona Inc (NASDAQ-XRAY), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Dentsply Sirona Inc (NASDAQ-XRAY) Stock Forecast & Technical Outlook

Review Dentsply Sirona Inc (NASDAQ-XRAY) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Dentsply Sirona Inc (NASDAQ-XRAY) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Dentsply Sirona Inc (NASDAQ-XRAY) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Buy

The daily technical read for Dentsply Sirona Inc (NASDAQ-XRAY) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Dentsply Sirona Inc (NASDAQ-XRAY) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Dentsply Sirona Inc (NASDAQ-XRAY) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Dentsply Sirona Inc (NASDAQ-XRAY)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Dentsply Sirona Inc (NASDAQ-XRAY) has a Hold consensus, with 2 buy, 12 hold and 0 sell recommendations in the current data set.

Buy 2
Hold 12
Sell 0
FAQ • Fast Investor Answers

Dentsply Sirona Inc (NASDAQ-XRAY) Stock FAQ

Data-supported answers about Dentsply Sirona Inc (NASDAQ-XRAY), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$14.28
Estimated upside 51.4%
Valuation Rating
Undervalued
Estimated upside of 51.4%
Analyst Target
$12.53
Implied upside 32.9%
Financial Health
Good
Current financial-health read

The current fair value estimate for Dentsply Sirona Inc (NASDAQ-XRAY) is $14.28. This implies an estimated upside of 51.4% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 51.4% versus the current market price.

The available analyst price target for Dentsply Sirona Inc (NASDAQ-XRAY) is $12.53. The analyst target implies estimated upside of 32.9%.

The current financial health read for Dentsply Sirona Inc (NASDAQ-XRAY) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Dentsply Sirona Inc (NASDAQ-XRAY) is November 5, 2026.

Based on the current data, dividend yield is 6.8%.

The current market capitalization listed for Dentsply Sirona Inc is 1.88 B.

The current enterprise value listed for Dentsply Sirona Inc is 3.968 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Dentsply Sirona Inc is NASDAQ-XRAY, and the stock is listed on NASDAQ.

Dentsply Sirona Inc (NASDAQ-XRAY) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Dentsply Sirona Inc is 55.3%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Dentsply Sirona Inc is 94.2%. Free float helps investors understand how much of the share base is available for public trading.